For citations:
The interview as part of the "Leadership Opinion" Series. Drug development & registration. 2025;14(2):10-12. (In Russ.)
The interview as part of the "Leadership Opinion" Series. Drug development & registration. 2025;14(2):10-12. (In Russ.)